Pine Valley Investments Ltd Liability Co Has $722,000 Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Pine Valley Investments Ltd Liability Co reduced its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 26.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 4,956 shares of the financial services provider’s stock after selling 1,745 shares during the period. Pine Valley Investments Ltd Liability Co’s holdings in iShares Biotechnology ETF were worth $722,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of IBB. Brookstone Capital Management increased its holdings in iShares Biotechnology ETF by 203.5% in the second quarter. Brookstone Capital Management now owns 20,117 shares of the financial services provider’s stock valued at $2,944,000 after purchasing an additional 13,488 shares during the period. Hoylecohen LLC bought a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at about $368,000. Raymond James & Associates increased its stake in shares of iShares Biotechnology ETF by 4.4% in the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after buying an additional 7,931 shares during the period. Williams Financial LLC bought a new position in shares of iShares Biotechnology ETF during the second quarter worth about $867,000. Finally, KFG Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF in the second quarter worth approximately $214,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.8 %

Shares of IBB stock opened at $136.61 on Friday. The business’s 50 day simple moving average is $141.84 and its 200 day simple moving average is $142.25. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The company also recently disclosed a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.